Cindy M. Pabon MD Anderson Cancer Center Hematology/Oncology Fellow & Quality Improvement Chief

 

Dr. Cindy Pabon received her medical degree from University of Floriday in 2018 and completed her internal medicine residency at Duke university in 2021. She is currently in her third year of her Hematology/Oncology Fellowship at MD Anderson and will be finished in 2024. She is interested in GI malignances with a focus on upper GI, clinical trial deigns, establishing clinical trial networks in safety net hospitals, and developing effective cross-cultural communication for end-of-life conversations.

JOIN HERE!

Objectives:

1.Demonstrate my path in medicine.
2.Illustrate how projects and trials can address specific clinical questions in challenging cancers*
3.Reflect on our community

FACULTY DISCLOSURES:

Dr. Pabon has indicated that she has no relevant financial relationship with commercial interests.

Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.

All the relevant financial relationships for these individuals have been mitigated.

TARGET AUDIENCE:
Faculty, Primary Care Physicians, APRNs, PharmD

ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.